Epidemiology of Onychomycosis

Ghannoum, Mahmoud A.; Salem, Islam Elbayoumi; Christensen, Luisa

doi:10.1002/9781119226512.ch2

Cited by 8 publications

(11 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Risk factors for the development of onychomycosis include advancing age [ 2 ], the presence of nail trauma or psoriasis, wearing occlusive footwear, participating in sporting activities like running or swimming, and a history of fungal infection elsewhere on the body [ 3 , 4 , 5 ]. A rise in the prevalence of onychomycosis over the past few decades has been attributed to a number of causes including an increase in the number of immunocompromised individuals (including people with diabetes) [ 6 ], longer life expectancies, increased urbanisation, and use of occlusive modern footwear [ 7 ].…”

Section: Onychomycosis and Associated Risksmentioning

confidence: 99%

“…Susceptibility to onychomycosis increases with the presence of other underlying comorbidities, including chronic renal failure (with dialysis) and renal transplant, immunodeficiency, diabetes, cancer and peripheral arterial disease [ 3 , 6 ]. These comorbidities and associated polypharmacy make some patients ineligible for oral antifungals.…”

Section: Treatment Challengesmentioning

confidence: 99%

See 1 more Smart Citation

Challenges and Opportunities in the Management of Onychomycosis

Christenson

Peterson

Naunton

et al. 2018

JoF

View full text Add to dashboard Cite

Onychomycosis is an increasingly common fungal nail infection, chiefly caused by dermatophyte fungi. The disease is notoriously difficult to treat due to the deep-seated nature of fungi within the nail plate, prolonged treatment requirements, poor patient adherence and frequent recurrences. Given the poor efficacy of currently available topical and systemic therapies, there is a renewed interest in exploring alternative treatment modalities for onychomycosis. Natural therapies, physical treatments and various combination therapies have all shown potential for the management of onychomycosis, though research on many of these methods is still in preliminary stages. Further large, well-designed, randomised controlled trials are necessary to confirm the efficacy of these novel treatments in order to make formal recommendations regarding their use in the management of onychomycosis.

show abstract

Section: Onychomycosis and Associated Risksmentioning

confidence: 99%

Section: Treatment Challengesmentioning

confidence: 99%

Challenges and Opportunities in the Management of Onychomycosis

Christenson

Peterson

Naunton

et al. 2018

JoF

View full text Add to dashboard Cite

show abstract

“…Onychomycosis (OM) is a fungal nail infection, also known as Tinea unguium [ 1 ], with estimated prevalence of 10–14% in the general population [ 2 , 3 , 4 ]. Although OM is considered an aesthetic problem [ 5 ], it is recognized as a risk factor, promoter of foot ulcers and enhancer of acute bacterial cellulitis, particularly in diabetics [ 6 , 7 , 8 ].…”

Section: Introductionmentioning

confidence: 99%

“…In Portugal, prevalence studies estimate rates between 17 and 47% [ 5 , 19 ], which is above the 10–14% estimated in the general population [ 2 , 3 , 4 ]. This discrepancy reinforces the need to study OM in the Portuguese population to understand the health impact, and because a previous study reported that the Portuguese geriatric population considered OM as an aesthetic condition, unless foot problems were present [ 5 ].…”

Section: Introductionmentioning

confidence: 99%

Translation and Cross-Cultural Adaptation of Quality of Life Scale in Patients with Onychomycosis

Silva-Neves

Rego

Alves

et al. 2021

IJERPH

View full text Add to dashboard Cite

(1) Background: Onychomycosis (OM) is a fungal nail infection, considered a risk factor for diabetic foot ulcers. It is associated with changes in quality of life, in terms of pain, self-confidence and self-esteem. The aim was to translate and adapt the OM quality of life questionnaire “OnyCOE-tTM–Quality Of Life Questionnaire Onychomycosis (Nail Fungal Condition)”. (2) Methods: This study followed the guidelines proposed by Beaton et al. (2000), where two English to Portuguese translations were performed and, after an expert consensus, a common version was obtained. This was followed by two back-translations. The expert committee achieved semantic equivalence, idioms and concepts. The pre-test was applied to 49 people. The final version and processed data were sent to the authors. (3) Results: We adapted terms semantically, modified statements syntactically, altering items from interrogative to affirmative. (4) Conclusions: The translated version of the “Quality of life–Onychomycosis” questionnaire suggested that it can be used for further studies to test validity and reliability in this population.

show abstract

“…Рост распространенности онихомикоза за последние десятилетия объясняется рядом причин, в том числе увеличением числа людей с ослабленным иммунитетом (включая людей с диабетом) [14], ростом продолжительности жизни и урбанизации, окклюзией, использованием современной обуви [15]. Грибковые инфекции заразны.…”

unclassified

Modern risk factors and features of treatment of onychomycosis

Sakania

Piruzyan

Korsunskaya

2020

Medicinskij alfavit

View full text Add to dashboard Cite

Onychomycosis is a widespread nail disease caused by dermatophytes, yeast and non‑dermatophytes. Risk factors for the development of onychomycosis can be various somatic conditions, for example diabetes, age, lifestyle features. Often onychomycosis occurs in athletes. According to some reports, 60.7 % of football players have this disease. The reason for the increased risk of developing onychomycosis in athletes is wearing unsuitable shoes, the frequent use of synthetic clothing and sweat‑preserving shoes, and injuries to the nail plates. Preference should be given to systemic therapy. Treatment can take up to 18 months, due to the slow regrowth of a healthy nail plate. Of the systemic drugs, itraconazole is widely used. The drug can be prescribed according to the scheme of pulse therapy, and positive dynamics is observed after 2 months of use.

show abstract

Epidemiology of Onychomycosis

Cited by 8 publications

References 26 publications

Challenges and Opportunities in the Management of Onychomycosis

Challenges and Opportunities in the Management of Onychomycosis

Translation and Cross-Cultural Adaptation of Quality of Life Scale in Patients with Onychomycosis

Modern risk factors and features of treatment of onychomycosis

Contact Info

Product

Resources

About